Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Kent

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2026
Corrigendum to "Activation of GPR183 by 7α,25-dihydroxycholesterol induces behavioral hypersensitivity through mitogen-activated protein kinase and nuclear factor-κB"Kathryn Braden, Michela Campolo, Ying Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 14, 2010
LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibitionRhalena Thomas, Kristy Favell, Jose Morante-Redolat, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2020
GPR183-Oxysterol Axis in Spinal Cord Contributes to Neuropathic PainKathryn Braden, Luigino Antonio Giancotti, Zhoumou Chen, et al.
Lancet (London, England)|October 17, 2024
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trialMary McCormack, Gemma Eminowicz, Dolores Gallardo, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2026
Corrigendum to "Activation of GPR183 by 7α,25-dihydroxycholesterol induces behavioral hypersensitivity through mitogen-activated protein kinase and nuclear factor-κB"Kathryn Braden, Michela Campolo, Ying Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 14, 2010
LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibitionRhalena Thomas, Kristy Favell, Jose Morante-Redolat, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2020
GPR183-Oxysterol Axis in Spinal Cord Contributes to Neuropathic PainKathryn Braden, Luigino Antonio Giancotti, Zhoumou Chen, et al.
Lancet (London, England)|October 17, 2024
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trialMary McCormack, Gemma Eminowicz, Dolores Gallardo, et al.
Pageof 7